Severe gastroesophageal reflux disease in children: causes and treatment approaches
A.A. KAMALOVA, V.P. BULATOV
Kazan State Medical University, Butlerov St., 49, Kazan, Russian Federation, 420012
Kamalova A.A. — D. Med. Sc., Associate Professor of the Department of Pediatrics, tel. (843) 237-30-37, e-mail: aelitakamalova@gmail.comBulatov V.P. — D. Med. Sc., Professor, Head of the Department of Pediatrics, tel. (843) 237-30-37, e-mail: bulatovkgmu@mail.ru
Despite the developed algorithms for diagnosis and treatment of the gastroesophageal reflux disease in children, there is a group of patients prone to severe disease that require individual approach and long-term monitoring because of the risk of subsequent serious complications such as Barrett’s esophagus and esophageal adenocarcinoma. The article describes the conditions and diseases associated with severe gastroesophageal reflux disease. The approaches to the treatment and its evaluation are presented.
Key words: gastroesophageal reflux disease, children, severe course.
REFERENCES
1. Privorotskiy V.F., Luppova N.E., Bel’mer S.V. et al. The working protocol of diagnosis and treatment of gastroesophageal reflux disease in children. Detskaya bol’nitsa, 2014, no. 1, pp. 54-61 (in Russ.).
2. Privorotskiy V.F., Luppova N.E. Proekt rabochego protokola diagnostiki i lecheniya gastroezofageal’noy reflyuksnoy bolezni. Materialy XII Kongressa detskikh gastroenterologov Rossii [The project is a working protocol of diagnosis and treatment of gastroesophageal reflux disease. Materials XII Congress of Russian pediatric gastroenterologists]. Moscow, 2005.
3. Vandenplas Y., Rudolph C. D., Di Lorenzo C. et al. Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). Journal of Pediatric Gastroenterology and Nutrition, 2009, vol. 49, rr. 498-547.
4. Hassall E., Kerr W., El-Sera HB. Characteristics of children receiving proton pump inhibitors continuously for up to 11 years duration. J Pediatr., 2007, vol. 150, rr. 262-7.
5. Hassall E. Outcomes of fundoplication: causes for concern, newer options. Arch Dis Child., 2005, vol. 90, rr. 1047-52.
6. Goldin A.B., Sawin R., Seidel K.D. et al. Do antireflux operations decrease the rate of reflux-related hospitalizations in children? Pediatrics, 2006, vol. 118, rr. 2326-33.
7. Bozkurt M., Tutuncuoglu S., Serdaroglu G. et al. Gastroesophageal reflux in children with cerebral palsy: efficacy of cisapride. J Child Neurol., 2004, vol. 19, rr. 973-6.
8. Pensabene L., Miele E., Giudice E.D. et al. Mechanisms of gastroesophageal reflux in children with sequelae of birth asphyxia. Brain Dev., 2008, vol. 30, rr. 563-71.
9. Luzzani S., Macchini F., Valade A. et al. Gastroesophageal reflux and Cornelia de Lange syndrome: typical and atypical symptoms. Am J Med Genet., 2003, vol. 119, rr. 283-7.
10. Gossler A., Schalamon J., Huber-Zeyringer A. et al. Gastroesophageal reflux and behavior in neurologically impaired children. J Pediatr Surg., 2007, vol. 42, rr. 1486-90.
11. Miele E., Staiano A., Tozzi A. et al. Clinical response to aminoacid-based formula in neurologically impaired children with refractory esophagitis. J Pediatr Gastroenterol Nutr., 2002, vol. 35, rr. 314-9.
12. Sleigh G., Brocklehurst P. Gastrostomy feeding in cerebral palsy: a systematic review. Arch Dis Child., 2004, vol. 89, rr. 534-9.
13. Catto-Smith A.G., Jimenez S. Morbidity and mortality after percutaneous endoscopic gastrostomy in children with neurological disability. J Gastroenterol Hepatol., 2006, vol. 21, rr. 734-8.
14. Vernon-Roberts A., Sullivan P.B. Fundoplication versus post-operative medication for gastro-oesophageal reflux in children with neurological impairment undergoing gastrostomy. Cochrane Database Syst Rev., 2007. CD006151.
15. Gilger M.A., Yeh C., Chiang J. et al. Outcomes of surgical fundoplication in children. Clin Gastroenterol Hepatol., 2004, vol. 2, rr. 978-84.
16. Mathei J., Coosemans W., Nafteux P. et al. Laparoscopic Nissen fundoplication in infants and children: analysis of 106 consecutive patients with special emphasis in neurologically impaired vs. neurologically normal patients. Surg Endosc., 2008, vol. 22, rr. 1054-9.
17. Lobe T.E. The current role of laparoscopic surgery for gastroesophageal reflux disease in infants and children. Surg Endosc., 2007, vol. 21, rr. 167-74.
18. Vakil N. Review article: the role of surgery in gastroesophageal reflux disease. Aliment Pharmacol Ther., 2007, vol. 25, rr. 1365-72.
19. El-Serag H. Role of obesity in GORD-related disorders. Gut, 2008, vol. 57, rr. 281-4.
20. Gerson L.B. A little weight gain, how much gastroesophageal reflux disease? Gastroenterology, 2006, vol. 131, rr. 1644-6.
21. Koivusalo A., Pakarinen M.P., Rintala R.J. The cumulative incidence of significant gastrooesophageal reflux in patients with oesophageal atresia with a distal fistula-a systematic clinical, pH-metric, and endoscopic follow-up study. J Pediatr Surg., 2007, vol. 42, rr. 370-4.
22. Taylor A.C., Breen K.J., Auldist A. et al. Gastroesophageal reflux and related pathology in adults who were born with esophageal atresia: along-term follow-up study. Clin Gastroenterol Hepatol., 2007, vol. 5, rr. 702-6.
23. Sistonen S.J., Koivusalo A., Lindahl H. et al. Cancer after repair of esophageal atresia: population-based long-term follow-up. J Pediatr Surg., 2008, vol. 43, rr. 602-5
24. Leeuwenburgh I., Van Dekken H., Scholten P. et al. Oesophagitis is common in patients with achalasia after pneumatic dilatation. Aliment Pharmacol Ther., 2006, vol. 23, rr. 1197-203.
25. Roberts K.E., Duffy A.J., Bell R.L. Controversies in the treatment of gastroesophageal reflux and achalasia. World J Gastroenterol., 2006, vol. 12, rr. 3155-61.
26. Boesch R.P., Acton J.D. Outcomes of fundoplication in children with cystic fibrosis. J Pediatr Surg., 2007, vol. 42, rr. 1341-4.
27. Jadcherla S., Rudolph C. Gastroesophageal reflux in the preterm neonate. Neoreviews, 2005, vol. 6, rr. 87-98.
28. Malcolm W.F., Gantz M., Martin R.J. et al. Use of medications for gastroesophageal reflux at discharge among extremely low birth weight infants. Pediatrics, 2008, vol. 121, rr. 22-7.
29. Jadcherla S.R, Gupta A., Fernandez S. et al. Spatiotemporal characteristics of acid refluxate and relationship to symptoms in premature and term infants with chronic lung disease. Am J Gastroenterol., 2008, vol. 103, rr. 720-8.
30. Magista A.M., Indrio F., Baldassarre M. et al. Multichannel intraluminal impedance to detect relationship between gastroesophageal reflux and apnoea of prematurity. Dig Liver Dis., 2007, vol. 39, rr. 216-21.
31. Lopez-Alonso M., Moya M.J., Cabo J.A. et al. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux. Pediatrics, 2006, vol. 118, rr. 299-308.
32. Finer N.N., Higgins R., Kattwinkel J. et al. Summary proceedings from the apnea-of-prematurity group. Pediatrics, 2006, vol. 117, rr. 47-51.
33. Misra S., Macwan K., Albert V. Transpyloric feeding in gastro-esophageal-reflux-associated apnea in premature infants. Acta Paediatr., 2007, vol. 96, rr. 1426-9.
34. Kaijser M., Akre O., Cnattingius S. et al. Preterm birth, lowbirth weight, and risk for esophageal adenocarcinoma. Gastroenterology, 2005, vol. 128, rr. 607-9.
35. Akre O., Forssell L., Kaijser M. et al. Perinatal risk factors for cancer of the esophagus and gastric cardia: a nested case-control study. Cancer Epidemiol Biomarkers Prev., 2006, vol. 15, rr. 867-71.